Asset Management Company | Portfolio
The company's lead product, Tauferon, is in Phase II human clinical studies ... Tauferon can be administered orally, which is a significant improvement over ...

This Is MS Forums - Summary of the pipeline | Unbiased Multiple ...
Interferon-tau (aka tauferon) (Pepgen) 29. Kynurenine (aka Tranilast) (Stanford and Pacific Pharmaceuticals) 30. L-000124467 (Mount Sinai Medical Center) ...

Product & Technology
Preclinical and human clinical studies have shown that Tauferon(tm) is ... Importantly, Tauferon(tm) is extremely well tolerated with an excellent safety profile. ...

Current Opinion in Neurology - Fulltext: Volume 19(3) June 2006 p ...
Interferon (IFN)- (Tauferon; an oral IFN), anti-IL-12 antibody and BG-12, an oral mixture of fumeric acid esters that inhibits the action of immune ...

portfolio
Pepgen's lead product, Tauferon(tm), is an orally administered compound in human ... Tauferon's major competitive advantages are its oral availability and a ...

Abstracts From ASENT 2004 Annual Meeting March 11-13, 2004
Upregulation of IL-10 in Patients Treated with Oral Tauferon ... In this report, we examined the ability of Tauferon to regulate IL-10 and IFN-g production ...

Microsoft PowerPoint - FREAR
Tauferon. 2010. IV. Genzyme. Campath. 2009. Oral. GlaxoSmithKline. GSK-683699. 2009. Oral. Novartis. FTY-720. 2008. Oral. sanofi-aventis. Teriflunomide ...

www.bioventureview.com
The second Phase II trial of Tauferon will start Q2/2005 and will ... interferon alpha that has certain aspects of Tauferon," he said. ...

I M P A C T
Tauferon. II. Questcor. Pharmaceuticals, Inc. Fabre Kramer Pharmaceuticals, Inc. Hypnostat. II. Renovis, Inc. REN-1189. III. Renovis, Inc. AstraZeneca ...

{1} Raises $7.5 Million In Private Financing To Complete Phase II ...
Tauferon can be administered orally, which is a significant improvement over ... Tauferon also has an excellent safety profile and does not generate ...